Systemic Therapy for Sjögren Closer With Phase 3 Success – Medscape

Written by

admin

in

  1. Systemic Therapy for Sjögren Closer With Phase 3 Success  Medscape
  2. Novartis drug reduces Sjögren’s activity, patient burden in late-stage trials despite notable placebo effect  Fierce Biotech
  3. Novel Biologic for Sjogren’s Clears Penultimate Hurdle  MedPage Today
  4. Sjögren’s patients on nipocalimab report less pain, dryness in trial  Sjogren’s Disease News
  5. Novartis Heralds Watershed Ianalumab Data In Sjogren’s  Citeline News & Insights

Continue Reading

More posts